BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2573565)

  • 1. Histamine-2-receptor antagonists in gastro-oesophageal reflux.
    Colin-Jones DG
    Gut; 1989 Oct; 30(10):1305-8. PubMed ID: 2573565
    [No Abstract]   [Full Text] [Related]  

  • 2. The medical management of gastro-oesophageal reflux.
    Drug Ther Bull; 1996 Jan; 34(1):1-4. PubMed ID: 8746191
    [No Abstract]   [Full Text] [Related]  

  • 3. Rationale for high-dose H2-receptor blockade in the treatment of gastro-oesophageal reflux disease.
    Castell DO
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():59-67. PubMed ID: 1679673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of treatment for gastro-oesophageal reflux.
    Laheij RJ; Jansen JB; Severens JL; Verbeek AL
    Gut; 1998 Nov; 43(5):728-9; author reply 729-30. PubMed ID: 9917194
    [No Abstract]   [Full Text] [Related]  

  • 5. Is it justified to give antisecretory drugs before an endoscopy in case of symptoms suggestive of gastro-oesophageal reflux disease? Société Royale Belge de Gastro-entérolgie.
    Galmiche JP; Delbende B; Zerbib F; Deltenre M; Jonas C; De Koster E; Devière H; Bouilliez D; Melot C; Urbain D
    Acta Gastroenterol Belg; 1998; 61(4):438-49. PubMed ID: 9923095
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost effectiveness of treatment for gastro-oesophageal reflux disease.
    Crawley JA
    Gut; 1998 Nov; 43(5):729-30. PubMed ID: 9917195
    [No Abstract]   [Full Text] [Related]  

  • 7. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO; Tutuian R
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastro-oesophageal reflux disease pathophysiology, diagnosis and management.
    Jayanthi V; Shankar VR
    J Assoc Physicians India; 1994 Mar; 42(3):235-9. PubMed ID: 7860516
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastro-oesophageal reflux disease.
    Moayyedi P; Delaney B; Forman D
    Clin Evid; 2005 Dec; (14):567-81. PubMed ID: 16620423
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastro-oesophageal reflux disease.
    Moayyedi P; Delaney B; Forman D
    Clin Evid; 2004 Jun; (11):583-600. PubMed ID: 15652024
    [No Abstract]   [Full Text] [Related]  

  • 11. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of gastro-oesophageal reflux disease.
    De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastro-oesophageal reflux disease.
    Moayyedi P; Delaney B; Forman D
    Clin Evid; 2003 Jun; (9):496-512. PubMed ID: 12967375
    [No Abstract]   [Full Text] [Related]  

  • 14. Correct use of proton pump inhibitors for gastro-oesophageal reflux disease.
    Hatlebakk JG; Emken BE; Glazkov V; Hoff DA; Hausken T
    Tidsskr Nor Laegeforen; 2013 Jan; 133(1):43-6. PubMed ID: 23306993
    [No Abstract]   [Full Text] [Related]  

  • 15. Acid suppression in gastro-oesophageal reflux disease: Why? How? How much and when?
    Jones MP
    Postgrad Med J; 2002 Aug; 78(922):465-8. PubMed ID: 12185218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHARMACOLOGICAL TREATMENT OF CHILDREN WITH GASTRO-ESOPHAGEAL REFLUX: A SUMMARY.
    Gaines C
    Gastroenterol Nurs; 2016; 39(1):68-70. PubMed ID: 26825568
    [No Abstract]   [Full Text] [Related]  

  • 18. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
    Juul-Hansen P; Rydning A
    Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the management of gastro-oesophageal reflux disease.
    Lee JM; O'Morain CA
    Postgrad Med J; 1998 Mar; 74(869):145-50. PubMed ID: 9640439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H2-receptor antagonists in the treatment of complicated gastroesophageal reflux disease: "for whom the bell tolls".
    Fennerty MB; Lieberman D
    Gastroenterology; 1994 Nov; 107(5):1545-8. PubMed ID: 7926519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.